Modulation of human bronchial epithelial cells by pneumococcal choline binding protein A

Human Immunology

Volumn 72, Issue 1, 2011, Pages 37-46

  Cao, Ju ^a   Gong, Yi ^b   Cai, Bei ^a   Feng, Weihua ^a   Wu, Yongkang ^a   Li, Lixin ^a   Zou, Yuangao ^a   Ying, Binwu ^a   Wang, Lanlan ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Adhesion molecule; Bronchial epithelial cell; Chemokine; Cytokine; Streptococcus pneumoniae

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADHESIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CHOLINE BINDING PROTEIN A; CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; CELL CULTURE; CELL SURFACE; CHEEK MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; INTERFERON INDUCTION; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; UPREGULATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; BACTERIAL PROTEINS; CELLS, CULTURED; CHEMOKINES; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RESPIRATORY MUCOSA;

EID: 78650174087     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.10.007     Document Type: Article

References (37)

1. van der Poll T., Opal S.M. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009, 374:1543-1546.
2. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154.
3. Dagan R., Klugman K.P. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 2008, 8:785-795.
4. O'Brien K.L., Hochman M., Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: Is hyporesponsiveness an issue?. Lancet Infect Dis 2007, 7:597-606.
5. López R., García E. Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol Rev 2004, 28:553-580.
6. Kadioglu A., Weiser J.N., Paton J.C., Andrew P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008, 6:288-301.
7. Rosenow C., Ryan P., Weiser J.N., Johnson S., Fontan P., Ortqvist A., Masure H.R. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol 1997, 25:819-829.
8. Dave S., Carmicle S., Hammerschmidt S., Pangburn M.K., McDaniel L.S. Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol 2004, 173:471-477.
9. Luo R., Mann B., Lewis W.S., Rowe A., Heath R., Stewart M.L., et al. Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae. EMBO J 2005, 24:34-43.
10. Zhang J.R., Mostov K.E., Lamm M.E., Nanno M., Shimida S., Ohwaki M., Tuomanen E. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 2000, 102:827-837.
11. Orihuela C.J., Gao G., Francis K.P., Yu J., Tuomanen E.I. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 2004, 190:1661-1669.
12. Barbier M., Agustí A., Albertí S. Fluticasone propionate reduces bacterial airway epithelial invasion. Eur Respir J 2008, 32:1283-1288.
13. Noske N., Kämmerer U., Rohde M., Hammerschmidt S. Pneumococcal interaction with human dendritic cells: Phagocytosis, survival, and induced adaptive immune response are manipulated by PavA. J Immunol 2009, 183:1952-1963.
14. Khair O.A., Davies R.J., Devalia J.L. Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 1996, 9:1913-1922.
15. Lu L., Ma Y., Zhang J.R. Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA. J Biol Chem 2006, 281:15464-15474.
16. Cao J., Chen D., Xu W., Chen T., Xu S., Luo J., et al. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Vaccine 2007, 25:4996-5005.
17. Hava D.L., LeMieux J., Camilli A. From nose to lung: The regulation behind Streptococcus pneumoniae virulence factors. Mol Microbiol 2003, 50:1103-1110.
18. McCool T.L., Cate T.R., Tuomanen E.I., Adrian P., Mitchell T.J., Weiser J.N. Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization. Infect Immun 2003, 71:5724-5732.
19. Murdoch C., Read R.C., Zhang Q., Finn A. Choline-binding protein A of Streptococcus pneumoniae elicits chemokine production and expression of intercellular adhesion molecule. 1 (CD54) by human alveolar epithelial cells. J Infect Dis 2002, 186:1253-1260.
20. Bernatoniene J., Zhang Q., Dogan S., Mitchell T.J., Paton J.C., Finn A. Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4, NF-kappaB, and mitogen-activated protein kinases. J Infect Dis 2008, 198:1823-1833.
21. Feldman C., Mitchell T.J., Andrew P.W., Boulnois G.J., Read R.C., Todd H.C., et al. The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. Microb Pathol 1990, 9:275-284.
22. Muller W.A. Mechanisms of transendothelial migration of leukocytes. Circ Res 2009, 105:223-230.
23. Rose-John S., Scheller J., Elson G., Jones S.A. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: Role in inflammation and cancer. J Leukoc Biol 2006, 80:227-236.
24. Winter C., Herbold W., Maus R., Länger F., Briles D.E., Paton J.C., et al. Important role for CC chemokine ligand 2-dependent lung mononuclear phagocyte recruitment to inhibit sepsis in mice infected with Streptococcus pneumoniae. J Immunol 2009, 182:4931-4937.
25. De Boer W.I. Cytokines and therapy in COPD: A promising combination?. Chest 2002, 121:209S-218S.
26. Dallaire F., Ouellet N., Bergeron Y., Turmel V., Gauthier M.C., Simard M., Bergeron M.G. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. J Infect Dis 2001, 184:292-300.
27. Chmura K., Bai X., Nakamura M., Kandasamy P., McGibney M., Kuronuma K., et al. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am J Physiol Lung Cell Mol Physiol 2008, 295:L220-L230.
28. Slevogt H., Schmeck B., Jonatat C., Zahlten J., Beermann W., van Laak V., et al. Moraxella catarrhalis induces inflammatory response of bronchial epithelial cells via MAPK and NF-kappaB activation and histone deacetylase activity reduction. Am J Physiol Lung Cell Mol Physiol 2006, 290:L818-L826.
29. Dong C., Davis R.J., Flavell R.A. MAP kinases in the immune response. Annu Rev Immunol 2002, 20:55-72.
30. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2:725-734.
31. Cao J., Wong C.K., Yin Y., Lam C.W. Activation of human bronchial epithelial cells by inflammatory cytokines IL-27 and TNF-alpha: Implications for immunopathophysiology of airway inflammation. J Cell Physiol 2010, 223:788-797.
32. Riise G.C., Larsson S., Andersson B.A. Bacterial adhesion to oropharyngeal and bronchial epithelial cells in smokers with chronic bronchitis and in healthy nonsmokers. Eur Respir J 1994, 7:1759-1764.
33. van Alphen L., Jansen H.M., Dankert J. Virulence factors in the colonization and persistence of bacteria in the airways. Am J Respir Crit Care Med 1995, 151:2094-2099.
34. Adamou J.E., Wizemann T.M., Barren P., Langermann S. Adherence of Streptococcus pneumoniae to human bronchial epithelial cells (BEAS-2B). Infect Immun 1998, 66:820-822.
35. Schmeck B., Zahlten J., Moog K., van Laak V., Huber S., Hocke A.C., et al. Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor. J Biol Chem 2004, 279:53241-53247.
36. Schmeck B., Moog K., Zahlten J., van Laak V., N'Guessan P.D., Opitz B., et al. Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1-dependent IL-8 release by lung epithelial BEAS-2B cells. Respir Res 2006, 7:98.
37. Cao J., Chen T., Li D., Wong C.K., Chen D., Xu W., et al. Mucosal immunization with purified ClpP could elicit protective efficacy against pneumococcal pneumonia and sepsis in mice. Microbes Infect 2008, 10:1536-1542.